Showing results (121-130 of 1,902) with videos related to
Sort By:
Pageof 191
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1995
Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemiaV Gandhi, E Estey, M Du, et al.Cancer Research|November 1, 1990
Pharmacologically directed design of the dose rate and schedule of 2',2'-difluorodeoxycytidine (Gemcitabine) administration in leukemiaR Grunewald, H Kantarjian, M J Keating, et al.Leukemia|August 1, 1987
Variables predicting response to high dose cytosine arabinoside therapy in patients with refractory acute leukemiaE Estey, W Plunkett, D Dixon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Cellular pharmacodynamics and plasma pharmacokinetics of parenterally infused hydroxyurea during a phase I clinical trial in chronic myelogenous leukemiaV Gandhi, W Plunkett, H Kantarjian, et al.Leukemia|March 1, 1996
Bcl-2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcomeL E Robertson, W Plunkett, K McConnell, et al.International Journal of Radiation Oncology, Biology, Physics|September 30, 1994
Fludarabine improves the therapeutic ratio of radiotherapy in mouse tumors after single-dose irradiationV Grégoire, N Hunter, W A Brock, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1983
High-dose cytosine arabinoside in non-Hodgkin's lymphomaH Kantarjian, B Barlogie, W Plunkett, et al.Leukemia|February 1, 1990
Cellular ara-CTP pharmacokinetics, response, and karyotype in newly diagnosed acute myelogenous leukemiaE H Estey, M J Keating, K B McCredie, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
High-dose mercaptopurine followed by intermediate-dose cytarabine in relapsed acute leukemiaS Lockhart, W Plunkett, S Jeha, et al.Seminars in Oncology|June 1, 1985
Pharmacologically directed ara-C therapy for refractory leukemiaW Plunkett, S Iacoboni, E Estey, et al.Pageof 191